Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis (original) (raw)

References

  1. Phillips, L. Infectious disease: TB's revenge. Nature 493, 14–16 (2013).
    Article Google Scholar
  2. Diacon, A. H. et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N. Engl. J. Med. 360, 2397–2405 (2009).
    Article Google Scholar
  3. Koul, A. et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nature Commun. 5, 3369 (2014).
    Article Google Scholar
  4. Koul, A. et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nature Chem. Biol. 3, 323–324 (2007).
    Article Google Scholar
  5. Koul, A. et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem. 283, 25273–25280 (2008).
    Article Google Scholar
  6. Andries, K. et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223–227 (2005).
    Article Google Scholar
  7. Peterson, E. J. et al. A high-resolution network model for global gene regulation in Mycobacterium tuberculosis. Nucleic Acids Res. 42, 11291–11303 (2015).
    Article Google Scholar
  8. Turkarslan, S. P. E. et al. A comprehensive map of genome-wide gene regulation in Mycobacterium tuberculosis. Sci. Data 2, 150010 (2015).
    Article Google Scholar
  9. Ma, S. et al. Integrated modeling of gene regulatory and metabolic networks in Mycobacterium tuberculosis. PLoS Comput. Biol. 11, e1004543 (2015).
    Article Google Scholar
  10. Chandrasekaran, S. & Price, N. D. Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 107, 17845–17850 (2010).
    Article Google Scholar
  11. Reiss, D. J., Baliga, N. S. & Bonneau, R. Integrated biclustering of heterogeneous genome-wide datasets for the inference of global regulatory networks. BMC Bioinformatics 7, 280 (2006).
    Article Google Scholar
  12. Lew, J. M., Kapopoulou, A., Jones, L. M. & Cole, S. T. TubercuList—10 years after. Tuberculosis (Edinb) 91, 1–7 (2011).
    Article Google Scholar
  13. Forrellad, M. A. et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4, 3–66 (2013).
    Article Google Scholar
  14. Senaratne, R. H. et al. Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice. J. Med. Microbiol. 57, 164–170 (2008).
    Article Google Scholar
  15. Shlomi, T., Cabili, M. N., Herrgard, M. J., Palsson, B. O. & Ruppin, E. Network-based prediction of human tissue-specific metabolism. Nature Biotechnol. 26, 1003–1010 (2008).
    Article Google Scholar
  16. Zur, H., Ruppin, E. & Shlomi, T. iMAT: an integrative metabolic analysis tool. Bioinformatics 26, 3140–3142 (2010).
    Article Google Scholar
  17. Rustad, T. R. et al. Mapping and manipulating the Mycobacterium tuberculosis transcriptome using a transcription factor overexpression-derived regulatory network. Genome Biol. 15, 502 (2014).
    Article Google Scholar
  18. Tufariello, J. M. et al. Enhanced specialized transduction using recombineering in Mycobacterium tuberculosis. mBio 5, e01179–e01114 (2014).
    Article Google Scholar
  19. Ioerger, T. R. et al. Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS ONE 8, e75245 (2013).
    Article Google Scholar
  20. Stover, C. K. et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405, 962–966 (2000).
    Article Google Scholar
  21. Minch, K. J. et al. The DNA-binding network of Mycobacterium tuberculosis. Nature Commun. 6, 5829 (2015).
    Article Google Scholar
  22. Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. Nature Biotechnol. 32, 1213–1222 (2014).
    Article Google Scholar
  23. Hards, K. et al. Bactericidal mode of action of bedaquiline. J. Antimicrob. Chemother. 70, 2028–2037 (2015).
    Google Scholar
  24. Berney, M., Hartman, T. E. & Jacobs, W. R. Jr. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline. mBio 5, e01275–e01214 (2014).
    Article Google Scholar
  25. Lu, P. et al. The cytochrome _bd_-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Sci. Rep. 5, 10333 (2015).
    Article Google Scholar
  26. Pethe, K. et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nature Med. 19, 1157–1160 (2013).
    Article Google Scholar
  27. Boshoff, H. I. et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279, 40174–40184 (2004).
    Article Google Scholar
  28. Telenti, A. et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647–650 (1993).
    Article Google Scholar
  29. Keren, I., Shah, D., Spoering, A., Kaldalu, N. & Lewis, K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186, 8172–8180 (2004).
    Article Google Scholar
  30. Keren, I., Kaldalu, N., Spoering, A., Wang, Y. & Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230, 13–18 (2004).
    Article Google Scholar
  31. Smith, P. A. & Romesberg, F. E. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. Nature Chem. Biol. 3, 549–556 (2007).
    Article Google Scholar
  32. Pandey, D. P. & Gerdes, K. Toxin–antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33, 966–976 (2005).
    Article Google Scholar
  33. Sala, A., Bordes, P. & Genevaux, P. Multiple toxin–antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel) 6, 1002–1020 (2014).
    Article Google Scholar
  34. Dhillon, J., Andries, K., Phillips, P. P. & Mitchison, D. A. Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells. Tuberculosis 90, 301–305 (2010).
    Article Google Scholar
  35. Diacon, A. H. et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet 380, 986–993 (2012).
    Article Google Scholar
  36. Tasneen, R. et al. Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis. Antimicrob. Agents Chemother. 55, 5485–5492 (2011).
    Article Google Scholar
  37. Our Pipeline: Regimens TB Alliance, (2016); http://www.tballiance.org/portfolio/regimens
  38. A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects with Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis (NC-005) (National Institutes of Health, 2015); https://clinicaltrials.gov/ct2/show/NCT02193776
  39. Diacon, A. H. et al. Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline. Am. J. Respir. Crit. Care Med. 191, 943–953 (2015).
    Article Google Scholar
  40. A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline plus PA-824 plus Linezolid in Subjects with Drug Resistant Pulmonary Tuberculosis (National Institutes of Health, 2015); https://clinicaltrials.gov/ct2/show/NCT02333799
  41. R Development Core Team. A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013).
  42. Rogers, D. J. & Tanimoto, T. T. A computer program for classifying plants. Science 132, 1115–1118 (1960).
    Article Google Scholar
  43. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
    Article Google Scholar
  44. Rustad, T. R., Harrell, M. I., Liao, R. & Sherman, D. R. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3, e1502 (2008).
    Article Google Scholar
  45. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
    Article Google Scholar
  46. Ma, S. et al. Integrated modeling of gene regulatory and metabolic networks in Mycobacterium tuberculosis. PLoS Comput. Biol. 11, 1004543 (2015).
    Article Google Scholar
  47. Becker, S. A. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nature Protoc. 2, 727–738 (2007).
    Article Google Scholar
  48. Schellenberger, J. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nature Protoc. 6, 1290–1307 (2011).
    Article Google Scholar
  49. Borisy, A. A. et al. Systematic discovery of multicomponent therapeutics. Proc. Natl Acad. Sci. USA 100, 7977–7982 (2003).
    Article Google Scholar

Download references